OPENING SESSION CHAIR: Ludwine Casteleyn, University of Leuven, Government of Flanders, Belgium
Conference Welcome J. Fernandes e Fernandes, Lisbon Faculty of Medicine F. George, Portugal, Directorate General of Health , João Gonçalves, Institute for the Environment, Portugal M. Fátima Reis, Organising Committee,
Context and background of Action 3 of the EC Environment and Health Action Plan 2004-2010 Birgit Van Tongelen, DG Environment, European Commission
Introduction to ESBIO objectives and work Reinhard Joas, BiPRO GmbH, Germany
SESSION 1 – Introduction to HBM, objectives and key issues CHAIR: Birgit Van Tongelen, DG Environment, European Commission
HBM: what is it and why do we need it? Ludwine Casteleyn, University of Leuven, Government of Flanders, Belgium
Biomonitoring - general requirements and situation in Germany Juergen Angerer, Institut für Arbeits-, Sozial- und Umweltmedizin der Universität Erlangen-Nürnberg, Germany
Problems and deficits in conducting HBM Marike Kolossa, Federal Environmental Agency, Germany
Overview on projects funded by DG Research, European Commission Marialuisa Tamborra, DG Research, European Comission
DISCUSSION
13:00 - 14:00
Lunch
14:00 - 16:00
SESSION 2 – HBM activities within Europe (Part 1) Country case studies Overview of HBM activities – research, surveillance, regulation … – executed or under development, reported by answering the following questions: why, what, where and how are we measuring?
Eight short oral communications (10 mn presentation + 5 mn discussion) will be accepted from scientists and/or country representatives with experience in biomonitoring
Attended Poster session A: HBM addressing exposure CHAIR / Reporter:Marek Jakubowski, Institute of Occupational Medicine, Poland
14:00 - 16:00
SESSION 2 – HBM activities within Europe (Part 1) Country case studies Overview of HBM activities – research, surveillance, regulation … – executed or under development, reported by answering the following questions: why, what, where and how are we measuring?
Parallel session B: HBM addressing adverse effects in health or quality of life CHAIR / Reporter:Ludwine Casteleyn, University of Leuven, Government of Flanders, Belgium
Eight short oral communications (10 mn presentation + 5 mn discussion) will be accepted from scientists and/or country representatives with experience in biomonitoring
Attended Poster session B: HBM addressing adverse effects in health or quality of life CHAIR / Reporter:Louis Bloemen, Environ Foundation, The Netherlands
14:00 - 16:00
SESSION 2 – HBM activities within Europe (Part 1) Country case studies Overview of HBM activities – research, surveillance, regulation … – executed or under development, reported by answering the following questions: why, what, where and how are we measuring?
Symposium on Integration of Environment and Health Data: Use of HBM as a Tool for Policymaking CHAIR / Reporter:Stella Michaelidou, Cyprus Committee on Children’s Environment and Healt
14:00-14:15 Environmental monitoring, biomonitoring and health surveillance for developing tools for Integrated Assessment of Health risks from environmental stressors (INTARESE) David Briggs, Department of Epidemiology and Public Health, Imperial College of Science, Technology and Medicine, UK.
14:15-14:30 Integrating Environmental and Human Biomonitoring: advantages and problems Greet Schoeters, Vito, Belgium
14:30-14:45 Biomonitoring as a tool to support Children’s Environment and Health policies Stella Michaelidou, Cyprus Committee on Children’s Environment and Health
Five more oral communications (10 mn presentation + 5 mn discussion) will be accepted from scientists and/or country representatives with experience in biomonitoring
Attended Poster session C: Integrating Environmental and Human Biomonitoring CHAIR / Reporter:Nadine Fréry, National Institute of Public Health Surveillance, France
SESSION 2 – HBM activities within Europe (Part 2) CHAIR / Reporter:Maria Botsivali, National Hellenic Research Foundation, Greece
WHO activities in Europe: overview of HBM actions, finished and ongoing Gerald Moy, WHO
WHO-coordinated exposure studies on levels of POPs in human milk Part 1. Concept and results of previous rounds Rainer Malisch, Gerald Moy and Rolaf van Leeuwen, WHO Part 2. Ongoing and future work Gerald Moy , Hae Jung Yoon and Rainer Malisch, WHO
HBM activities / programmes by Industry Peter Boogaard, CONCAWE, Belgium
SESSION 2 – HBM activities within Europe (Part 3) CHAIR:Reinhard Joas, BiPRO GmbH, Germany
Updated inventory of surveillance and research M. Fátima Reis Institute of Preventive Medicine, Portugal João Tedim, Senso Comum Lda, Portugal
A coordinated approach to HBM in Europe: the way forward / state of affairs of the Pilot Project Alexandra Weiss, BiPRO GmbH, Germany Birgit Van Tongelen, DG Environment,European Commission Ludwine Casteleyn, University of Leuven, Belgium
SESSION 3 – USA perpectives on HBM CHAIR:Greet Schoeters, Flemish Institute of Environmental Technology, Belgium
Activities and aims of HBM in the USA Larry Needham, Centers for Disease Control and Prevention (CDC), USA
12:30 - 13:00
CLOSING SESSION CHAIR:Birgit Van Tongelen, DG Environment, European Commission
Conference conclusions Reinhard Joas, Birgit Van Tongelen, Maria Botsivali, Stella Michaelidou, Ludwine Casteleyn and WPs leaders (M. Fátima Reis, Marike Kolossa, Greet Schoeters, Marek Jakubowski)
Closing ceremony Birgit Van Tongelen, DG Environment Marialuisa Tamborra, DG Research, European Comission Reinhard Joas, ESBIO J. Pereira Miguel, High Commissioner’s Office for Health J. Sentieiro, Science and Technology Foundation M. Fátima Reis, Organizing Committee
Thursday 28/9/2006:
Developed as a collaborative work between Senso Comum Lda and Institute of Preventive Medicine, Lisbon Faculty of Medicine, Portugal.
This web-site does not constitute a formal communication and does not necessarily represent the official position of the European Commission or Member States.
ESBIO project is funded by the European Commission (Directorate-General Research) under the 6th Framework Programme for Research and Technological Development in close cooperation with Directorate-General Environment
